Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method
Following PTZ injections, mice were placed in empty cages for 30 min for behavioural assessment of seizure development by a blinded, independent volunteer as 0 (no abnormalities), 1 (mouth and facial movements), 2 (head nodding), 3 (forelimb clonus), 4 (rearing) and 5 (rearing followed by falling or death) points
4-6wks Typical cycle duration with proper medical monitoring and planned rest periods 1x/day Once-daily subcutaneous injection due to extended half-life Questions IGF-1 LR3 features a 13-amino acid N-terminal extension that extends its half-life from minutes to 20-30 hours and reduces binding to IGF binding proteins
Dhatariya (MDText.com, Inc)
GLP-1 RAs STEP 1 (2021) : Semaglutide 2.4 ./ 14.9% 68 2.4% (Wilding et al., 2021, NEJM) SURMOUNT-1 (2022) : Tirzepatide (GLP-1/GIP dual agonist) 15 ./ 20.9% (Jastreboff et al., 2022, NEJM) GLP-1 HbA1c () 2 (Hypoglycemia) Glucose-dependent LEADER (liraglutide) SUSTAIN-6 (semaglutide) 2024 FDA Semaglutide (Wegovy) FLOW (2024) semaglutide (MASLD/NAFLD) GLP-1 RAs GLP-1
Treatment selection should be individualized based on clinical priorities and patient characteristics
)
.webp)
